Proton Co., Ltd. is a company engaged in biomedical contract customized R&D and production services, and its ** is listed and traded on the Shenzhen ** Stock Exchange. Proton shares are 300363.
Founded in 2005, Proton Co., Ltd. is an enterprise focusing on biopharmaceutical contract customized R&D and production services (CDMO). Since 2014, Proton shares have been listed on the Shenzhen Stock Exchange, which is the 300363.
As a leading biopharmaceutical CDMO company in China, Proton is committed to providing global customers with a full range of solutions from drug discovery, development to production. The company's business covers the fields of small molecules, large molecules and biological agents, and has strong technical strength and market competitiveness.
When investing in Proton shares, investors need to pay attention to the company's performance, industry dynamics, policies and regulations and other factors. At the same time, investors are advised to remain rational in the investment process, follow the principles of value investment, and make wise decisions according to their own risk tolerance and investment goals.
Proton shares are 300363, and investors can trade on the Shenzhen Exchange. In the investment process, it is recommended that investors pay attention to the company's performance, industry dynamics and other factors, remain rational and make wise decisions.